Shihong Chen

Shihong Chen

Auto-generated profile, based on publicly available information

Shihong Chen

Zhejiang Starry Pharmaceutical Co. Ltd., Xianju 317300, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2014 in Molecules
Verified
Journal Article
Open access
PDF file
TZTingting Zhang
Tingting Zhang
JWJinwei Wu
Jinwei Wu
SCShihong Chen
Shihong Chen
KLKaixiang Liu
Kaixiang Liu
LMLiu Mingliang
Liu Mingliang
MLMingliang Liu
Mingliang Liu
A series of amino acid and dipeptide prodrugs of IMB-070593, a fluoroquinolone candidate discovered in our lab, were synthesized and evaluated for their water solubility and then antibacterial activity. Our results reveal that four amino acid prodrugs 4a,b,e,f and two dipeptide prodrugs 4k,l have much greater solubility (>85 mg/mL) than IMB-070593 mesylate (22.5 mg/mL). Compounds 4a and 4k show good in vivo efficacy against MSSA 12-1 (p.o./i.v., 5.32–7.68 mg/kg) and S. pneumoniae12-10 (p.o., 18.39–23.13 mg/kg) which is 1.19–1.50 fold more active than the parent drug.